-
Hansen Medical Names Peter J. Mariani Chief Financial Officer
Friday, June 3, 2011 - 4:01pm | 113Hansen Medical (NASDAQ: HNSN) today announced that veteran financial executive Peter J. Mariani has been named Chief Financial Officer, effective June 20. He will report directly to President and Chief Executive Officer Bruce Barclay. Mariani replaces Peter Osborne, who has served as interim CFO...
-
WBB Upgrades Cyberonics to Strong Buy, Reiterates PT of $38
Friday, June 3, 2011 - 8:45am | 157WBB Securities upgraded its rating on Cyberonics (NASDAQ: CYBX) to Strong Buy. At the same time, WBB left its price target on the company's stock unchanged at $38. In a research report published today, WBB stressed Cyberonics' strong position in the epilepsy treatment market for its decision. In...
-
UPDATE: Piper Jaffray Lowers PT on Cyberonics to $35
Friday, June 3, 2011 - 7:31am | 82Piper Jaffray is out with its report today on Cyberonics (NASDAQ: CYBX), lowering its PT from $38 to $35. In a note to clients, Piper Jaffray writes, "We are lowering our price target from $38 to $35 based on our lower CY12 EPS estimate of $1.28 plus the inherent value of the company's substantial...
-
Piper Jaffray Lowers PT On Cyberonics To $35
Friday, June 3, 2011 - 6:03am | 26Piper Jaffray has lowered the price target on Cyberonics (NASDAQ: CYBX) from $38 to $35 and maintains its Overweight rating.
-
Masimo Initiates Limited Market Release of E1, Single-Patient-Use Ear Sensor for Pulse Oximetry Monitoring
Thursday, June 2, 2011 - 1:47pm | 110Masimo (NASDAQ: MASI) announced today FDA 510(k) Clearance, CE Mark, and limited market release of the industry's first single-patient-use ear sensor. Compared to digit sensors, the Masimo E1™ enables faster detection of oxygen saturation changes during low perfusion due to a variety of clinical...
-
Options Brief: Hospira, Inc.
Thursday, June 2, 2011 - 11:36am | 79Shares of Hospira, Inc. (NYSE: HSP) are lower on the session by 0.75%, trading at $54.48. Overall put volume is now running at 3.76x the daily average, with 52% of all puts traded being purchases on the offer. 2,197 contracts have traded on the session so far. Hospira, Inc. is a specialty...
-
Morgan Stanley Maintains Equal-Weight on Hologic
Thursday, June 2, 2011 - 9:45am | 144Morgan Stanley is out with its report today on Hologic (NASDAQ: HOLX), maintaining Equal-weight. In a note to clients, Morgan Stanley writes, "Hologic's strategy is sound and we are encouraged by the immediate accretion, but returns on capital are less clear and likely hinge on longer-term...
-
Vision-Sciences Signs Three Year Supply Agreement With Novation to Provide Unique EndoSheath Endoscopy Systems
Thursday, June 2, 2011 - 9:16am | 157Vision-Sciences, Inc. (Nasdaq: VSCI) announced today the signing of a comprehensive three-year equipment supply agreement with Novation LLC, one of the nation's largest group purchasing organizations. This agreement will allow the members of VHA Inc., University HealthSystem Consortium and Provista...
-
ThermoGenesis Announces 510(k) Approval for Use of Res-Q in Preparation of Platelet Rich Plasma
Thursday, June 2, 2011 - 9:01am | 219ThermoGenesis Corp. (NASDAQ: KOOL) said today it has received FDA clearance of its 510(k) submission for the use of its Res-Q™ 60 (Res-Q) System technology to be used for the safe and rapid preparation of autologous platelet rich plasma from a small sample of blood at the patient's point-of-care....
-
Piper Jaffray Reports on Hologic
Thursday, June 2, 2011 - 7:52am | 175Piper Jaffray commented on Hologic (NASDAQ: HOLX) in a report released today. In the report, Piper Jaffray was positive in its assessment of the company. Piper Jaffray writes, " FDA released the monthly MQSA National Statistics update, with 9,571 accredited full field digital mammography (FFDM)...
-
J.P. Morgan Maintains OW Rating on Hospira Following Management Meeting
Thursday, June 2, 2011 - 7:46am | 94J.P. Morgan recently met with Hospira's (NYSE: HSP) management team “and wanted to share our quick takeaways and highlights from the discussion.” “Specifically, we remain upbeat about generic Taxotere dynamics and comfortable with our above guidance forecast of $4.05 for 2011 EPS,” J.P. Morgan...
-
Benchmark Reiterates Buy on Analogic Corporation
Thursday, June 2, 2011 - 6:27am | 136Benchmark reiterated its Buy rating on Analogic Corporation (NASDAQ: ALOG) ahead of the company's quarterly earnings report, which is due on Tuesday, June 7. In a research report published today, Benchmark states, "We continue to like the stock based on upside from both medical and security in the...
-
Earnings Scheduled For June 2
Thursday, June 2, 2011 - 12:59am | 420Cascade Corporation (NYSE: CASC) is estimated to report its Q1 EPS at $0.82 on revenue of $113.33 million. SAIC Inc (NYSE: SAI) is projected to report its Q1 EPS at $0.33 on revenue of $2.71 billion. The Descartes Systems Group Inc (NASDAQ: DSGX) is projected to report its Q1 EPS at $0.12 on...
-
Anika Therapeutics Announces U.S. Distribution Agreement for Advanced Wound Care Product
Wednesday, June 1, 2011 - 4:18pm | 112Anika Therapeutics, Inc. (Nasdaq: ANIK), a leader in products for tissue protection, healing, and repair, based on hyaluronic acid technology, today announced Anika Therapeutics S.r.l., its wholly owned subsidiary, has entered into a new, five-year exclusive U.S. distribution agreement with Misonix...
-
Hologic Acquires TCT International Co for $135M
Wednesday, June 1, 2011 - 4:02pm | 98Hologic, Inc. (Nasdaq: HOLX) today announced it has acquired TCT International Co. Ltd., a distributor of medical products in China, including Hologic's ThinPrep Pap Test, related instruments and other diagnostic and surgical products. The purchase price for the transaction is $135 million in...